Zydus Lifesciences Limited

NSEI:ZYDUSLIFE 株式レポート

時価総額：₹1.1t

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Zydus Lifesciences マネジメント

マネジメント 基準チェック /24

Zydus Lifesciences'の CEO はSharvil Patelで、 Apr2017年に任命され、 の在任期間は 7.17年です。 の年間総報酬は₹ 262.50Mで、 68.6%給与と31.4%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.001%を直接所有しており、その価値は₹ 16.23M 。経営陣と取締役会の平均在任期間はそれぞれ6.1年と9.1年です。

主要情報

Sharvil Patel

最高経営責任者

₹262.5m

報酬総額

CEO給与比率68.6%
CEO在任期間7.2yrs
CEOの所有権0.001%
経営陣の平均在職期間6.1yrs
取締役会の平均在任期間9.1yrs

経営陣の近況

Recent updates

Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year

Jun 20
Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year

Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt

Jun 10
Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt

Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year

May 25
Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year

Does Zydus Lifesciences (NSE:ZYDUSLIFE) Deserve A Spot On Your Watchlist?

Mar 18
Does Zydus Lifesciences (NSE:ZYDUSLIFE) Deserve A Spot On Your Watchlist?

Earnings Not Telling The Story For Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Shares Rise 28%

Feb 28
Earnings Not Telling The Story For Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Shares Rise 28%

Analyst Estimates: Here's What Brokers Think Of Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Its Third-Quarter Report

Feb 12
Analyst Estimates: Here's What Brokers Think Of Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Its Third-Quarter Report

Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt

Dec 27
Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt

Here's Why Zydus Lifesciences (NSE:ZYDUSLIFE) Has Caught The Eye Of Investors

Dec 06
Here's Why Zydus Lifesciences (NSE:ZYDUSLIFE) Has Caught The Eye Of Investors

With EPS Growth And More, Zydus Lifesciences (NSE:ZYDUSLIFE) Makes An Interesting Case

Aug 23
With EPS Growth And More, Zydus Lifesciences (NSE:ZYDUSLIFE) Makes An Interesting Case

Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00

Jul 17
Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00

We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt

Jul 15
We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt

Zydus Lifesciences' (NSE:ZYDUSLIFE) Upcoming Dividend Will Be Larger Than Last Year's

Jun 24
Zydus Lifesciences' (NSE:ZYDUSLIFE) Upcoming Dividend Will Be Larger Than Last Year's

Zydus Lifesciences (NSE:ZYDUSLIFE) Is Increasing Its Dividend To ₹6.00

Jun 10
Zydus Lifesciences (NSE:ZYDUSLIFE) Is Increasing Its Dividend To ₹6.00

Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00

May 21
Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00

Zydus Lifesciences (NSE:ZYDUSLIFE) Seems To Use Debt Quite Sensibly

Feb 15
Zydus Lifesciences (NSE:ZYDUSLIFE) Seems To Use Debt Quite Sensibly

We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt

Nov 13
We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt

Zydus Lifesciences Limited (NSE:ZYDUSLIFE) Shares Could Be 23% Below Their Intrinsic Value Estimate

Aug 09
Zydus Lifesciences Limited (NSE:ZYDUSLIFE) Shares Could Be 23% Below Their Intrinsic Value Estimate

Zydus Lifesciences' (NSE:ZYDUSLIFE) Shareholders Will Receive A Smaller Dividend Than Last Year

Jul 25
Zydus Lifesciences' (NSE:ZYDUSLIFE) Shareholders Will Receive A Smaller Dividend Than Last Year

Zydus Lifesciences (NSE:ZYDUSLIFE) Has Announced That Its Dividend Will Be Reduced To ₹2.50

Jul 10
Zydus Lifesciences (NSE:ZYDUSLIFE) Has Announced That Its Dividend Will Be Reduced To ₹2.50

CEO報酬分析

Zydus Lifesciences の収益と比較して、Sharvil Patel の報酬はどのように変化したか？
日付総報酬給与会社業績
Mar 31 2024n/an/a

₹38b

Dec 31 2023n/an/a

₹30b

Sep 30 2023n/an/a

₹28b

Jun 30 2023n/an/a

₹25b

Mar 31 2023₹263m₹180m

₹20b

Dec 31 2022n/an/a

₹21b

Sep 30 2022n/an/a

₹20b

Jun 30 2022n/an/a

₹22b

Mar 31 2022₹200m₹180m

₹22b

Dec 31 2021n/an/a

₹23b

Sep 30 2021n/an/a

₹23b

Jun 30 2021n/an/a

₹23b

Mar 31 2021₹263m₹180m

₹22b

Dec 31 2020n/an/a

₹18b

Sep 30 2020n/an/a

₹17b

Jun 30 2020n/an/a

₹13b

Mar 31 2020₹250m₹247m

₹12b

Dec 31 2019n/an/a

₹12b

Sep 30 2019n/an/a

₹14b

Jun 30 2019n/an/a

₹17b

Mar 31 2019₹250m₹248m

₹18b

Dec 31 2018n/an/a

₹20b

Sep 30 2018n/an/a

₹20b

Jun 30 2018n/an/a

₹21b

Mar 31 2018₹250m₹248m

₹18b

報酬と市場: Sharvilの 総報酬 ($USD 3.15M ) は、 Indian市場 ($USD 974.46K ) の同規模の企業の平均を上回っています。

報酬と収益: Sharvilの報酬は過去 1 年間で 20% 以上増加しました。

CEO（最高経営責任者

Sharvil Patel (45 yo)

7.2yrs

在職期間

₹262,500,000

報酬

Dr. Sharvil Pankajbhai Patel has been Managing Director of Zydus Lifesciences Limited (formerly known as Cadila Healthcare Limited) since April 1, 2017 and previously served as its Joint Managing Director...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Sharvil Patel
MD & Executive Director7.2yrs₹262.50m0.0015%
₹ 16.0m
Ganesh Nayak
COO & Executive Director6.9yrs₹120.00m0.035%
₹ 377.8m
Punit Patel
President & CEO of Americaless than a yearデータなしデータなし
Nitinkumar Parekh
Chief Financial Officerno data₹54.31mデータなし
Arvind Bothra
Head of Investor Relationsno dataデータなしデータなし
Dhaval Soni
Company Secretary & Compliance Officer5.3yrs₹2.09mデータなし

6.1yrs

平均在職期間

経験豊富な経営陣: ZYDUSLIFEの経営陣は経験豊富で経験豊富です（平均在職期間は6.1年）。

取締役

名称ポジション在職期間報酬所有権
Sharvil Patel
MD & Executive Director26.8yrs₹262.50m0.0015%
₹ 16.0m
Ganesh Nayak
COO & Executive Director6.9yrs₹120.00m0.035%
₹ 377.8m
Pankaj Patel
Non-Executive Chairman29.1yrs₹1.60m74.98%
₹ 818.6b
Apurva Diwanji
Independent Director8.1yrs₹4.60mデータなし
Mukeshbhai Patel
Non-Executive Non-Independent Director26.8yrs₹4.80m0.0012%
₹ 12.7m
Bhadresh Shah
Independent Director5.5yrs₹4.60mデータなし
Dharmishtaben Raval
Non-Executive Independent Director10.1yrs₹4.50mデータなし
Nitin Desai
Non-Executive Independent Director13.1yrs₹4.30m0.046%
₹ 505.8m
Akhil Monappa
Independent Director1.6yrs₹1.20mデータなし
Upasana Konidela
Independent Director1.6yrs₹1.20mデータなし

9.1yrs

平均在職期間

69yo

平均年齢

経験豊富なボード: ZYDUSLIFEの 取締役会 は 経験豊富 であると考えられます ( 9.1年の平均在任期間)。